Pre-Clinical Study Highlights CERAMENT’s Bone Remodeling Properties

Pre-clinical study results demonstrated that BONESUPPORT's CERAMENT™, loaded with recombinant human bone morphogenic protein 2 (rhBMP-2) + zoledronic acid (ZA) in very low doses, was able to quantitatively/qualitatively generate a high amount of mineralized bone volume. Further, the study showed In vivo that mineralized volume was...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us